Lymphoid Abnormalities in CD40 Ligand Transgenic Mice Suggest the Need for Tight Regulation in Gene Therapy Approaches to Hyper Immunoglobulin M (IgM) Syndrome

Cancer Gene Therapy - United Kingdom
doi 10.1038/sj.cgt.7700232
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

121. Targeted Gene Therapy in the Treatment of X-Linked Hyper IgM Syndrome

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2015English

Hyper IgM Syndrome Associated With Defective CD40-mediated B Cell Activation.

Journal of Clinical Investigation
Medicine
1994English

Defective Expression of the CD40 Ligand in X Chromosome-Linked Immunoglobulin Deficiency With Normal or Elevated IgM.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1993English

Hyper-Immunoglobulin a in the Hyperimmunoglobulinemia D Syndrome

Clinical Diagnostic Laboratory Immunology
2001English

Blockade of CD40/CD40 Ligand Interactions Attenuates Skin Fibrosis and Autoimmunity in the Tight-Skin Mouse

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2008English

Hyper IgM Syndrome: Two Mutations Distinguish HIM.

Journal of Clinical Investigation
Medicine
1994English

Humoral Immune Responses in CD40 Ligand-Deficient Mice

Journal of Experimental Medicine
MedicineAllergyImmunology
1994English

Regulation of the Human C-Reactive Protein Gene in Transgenic Mice

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
1995English

Neuroanatomical Abnormalities in Behaviorally Characterized APPV717F Transgenic Mice

Neurobiology of Disease
Neurology
2000English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy